Lupin on Tuesday said it has gotten endorsement from the US wellbeing controller to showcase Meloxicam cases, used to treat osteoarthritis torment, in the American market.

The organization has gotten endorsement from the US Food and Drug Administration (USFDA) for meloxicam cases in quality of 5 mg and 10 mg, Lupin Ltd said in an announcement.

The Mumbai-based organization's item is the conventional variant of Zyla Life Sciences US, Inc's Vivlodex cases, it included.

"The item would be fabricated at organization's Aurangabad office, and is relied upon to be propelled presently," the medication creator said.

Meloxicam containers, 5 mg and 10 mg, are demonstrated for the board of osteoarthritis (OA) torment.

As per IQVIA MAT March 2020 information, Meloxicam cases had yearly deals of around $14 million in the US.